CRISPR Therapeutics Has Turned the Corner

Here's our current price target.

Johnson & Johnson Appears to Be Running Out of Steam

The shares of the healthcare giant have been in a long-term uptrend but could break that trend in the weeks ahead.

Anthem's Long-Term Uptrend Is Losing Its Vigor

The technical signals of the health benefits provider are weakening.

Here Are 2 Prudent Healthcare Trades

The country might be heading into recession, but folks still need to get their medicine, good times or bad.

Here's the Level to Zero In on for UnitedHealth Group

Shares of the diversified healthcare company have held up fairly well despite the decline in the broader market but soon could be put to the test.

3 Dividend-Paying Healthcare Stocks That Age Well

Within the next 15 years, people 65 or older are expected outnumber those under 18, for the first time in U.S. history.

Care to Play the Biotech Lottery? Here Are 3 Tickets I'm Holding

These are stocks that could hit or become insolvent, so they aren't for the faint of heart.

Boston Scientific Could Be Wicked Good in This Kind of Market

Here's why this healthcare stock is a potential port in the storm for investors.

2 Biotech Stocks to Own as M&A Potentially Gathers Steam

I like these names as stand-alone entities but they should also attract interest from larger players.

China Faces 'Tsunami' of Covid Infection That Could Swamp the System

A new study suggests 1.55 million people could die if China abandons zero-Covid, with the intensive-care system needing 15.6 times existing capacity.